European cardiology at the crossroads

Hemodynamic performance during exercise in patients with severe chronic congestive heart failure before and after a single dose of pimobendan.

Journal of cardiovascular pharmacology·1994

Calcium sensitization with pimobendan: pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure.

European heart journal·1993

Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris.

Journal of cardiovascular pharmacology·1991

Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan.

American heart journal·1991

Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing.

Journal of cardiovascular pharmacology·1989

Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

The American journal of cardiology·1989

Joint association between FIB-4 index and advanced cardiovascular-kidney-metabolic syndrome with aortic valve calcification: a community cohort in China.

Acta cardiologica·2026

Performance of a high-sensitivity troponin-based early rule-out pathway for suspected myocardial infarction.

Acta cardiologica·2026

Intramuscular penicillin prophylaxis and valve progression in adults with mild rheumatic heart disease: a propensity score-matched cohort study.

Acta cardiologica·2026

Acetazolamide, residual congestion and clinical outcomes in acute heart failure - a prespecified analysis of the ADVOR trial.

Acta cardiologica·2026

Circulating free fatty acid signatures discriminate myocardial infarction and systemic arterial hypertension.

Acta cardiologica·2026

Epidemiology and clinical features of acute coronary syndrome patients in selected hospitals in Greece: the CALLINICUS-Hellas registry.

Acta cardiologica·2026

One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.

Molecular medicine reports·2026

Blood urea nitrogen-to-albumin ratio and in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Biomolecules & biomedicine·2026

EXPRESS: Comparison of SABIHA and 3CPO Scores for 30-day Mortality in Acute Heart Failure.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026

Preoperative Therapeutic Plasma Exchange for Severe Hypertriglyceridemia-Associated Myocardial Infarction in a Chronic Hemodialysis Patient Undergoing Urgent Coronary Artery Bypass Grafting: A Case Report.

Case reports in nephrology and dialysis·2026

Related Experiment Videos

European cardiology at the crossroads

Related Concept Videos

Hemodynamic performance during exercise in patients with severe chronic congestive heart failure before and after a single dose of pimobendan.

Calcium sensitization with pimobendan: pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure.

Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris.

Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan.

Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing.

Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Joint association between FIB-4 index and advanced cardiovascular-kidney-metabolic syndrome with aortic valve calcification: a community cohort in China.

Performance of a high-sensitivity troponin-based early rule-out pathway for suspected myocardial infarction.

Intramuscular penicillin prophylaxis and valve progression in adults with mild rheumatic heart disease: a propensity score-matched cohort study.

Acetazolamide, residual congestion and clinical outcomes in acute heart failure - a prespecified analysis of the ADVOR trial.

Circulating free fatty acid signatures discriminate myocardial infarction and systemic arterial hypertension.

Epidemiology and clinical features of acute coronary syndrome patients in selected hospitals in Greece: the CALLINICUS-Hellas registry.

One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.

Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.

Blood urea nitrogen-to-albumin ratio and in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

EXPRESS: Comparison of SABIHA and 3CPO Scores for 30-day Mortality in Acute Heart Failure.

Preoperative Therapeutic Plasma Exchange for Severe Hypertriglyceridemia-Associated Myocardial Infarction in a Chronic Hemodialysis Patient Undergoing Urgent Coronary Artery Bypass Grafting: A Case Report.

Related Experiment Videos

European cardiology at the crossroads

Related Concept Videos

Related Articles